![Sinil Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sinil Kim
No más puestos en curso
Perfil
Sinil Kim worked as a Principal at Pfizer Inc. and as the Chief Medical Officer & Vice President-Oncology at Mirna Therapeutics, Inc. before pursuing undergraduate and doctorate degrees at the University of Washington.
Antiguos cargos conocidos de Sinil Kim.
Empresas | Cargo | Fin |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
Mirna Therapeutics, Inc.
![]() Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Director Técnico/Científico/I+D | 25/04/2016 |
Formación de Sinil Kim.
University of Washington | Doctorate Degree |
Experiencias
Funciones ocupadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PFIZER, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Mirna Therapeutics, Inc.
![]() Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
- Bolsa de valores
- Insiders
- Sinil Kim